SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptid
Kurzübersicht für SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptid (ABIN983685)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Sequenz
- IWKKVAEKEE LEQGSRPAPT LEEEKIRSLS SSSRNIQQML ADSINRMKAY
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SH2D4A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SH2D4A (SH2 Domain Containing 4A (SH2D4A))
-
Hintergrund
-
SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. SH2D4A may play a role in T-cell development and function.
Alias Symbols: FLJ20967, SH2A, PPP1R38
Protein Size: 454 -
Molekulargewicht
- 53 kDa
-
Gen-ID
- 63898
-
NCBI Accession
- NM_022071, NP_071354
-
UniProt
- Q9H788
Target
-